Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mona Sadeghalvad

Showing results (1-10 of 19) with videos related to

Pageof 2
Sort By:
Expert Opinion on Biological Therapy|April 2, 2021
An inflammatory triangle in Sarcoidosis: PPAR-γ, immune microenvironment, and inflammationParnia Jabbari, Mona Sadeghalvad, Nima Rezaei
Frontiers in Immunology|October 9, 2023
Flow cytometric analysis of innate lymphoid cells: challenges and solutionsMona Sadeghalvad, Davit Khijakadze, Mona Orangi, et al.
Breast Cancer Research and Treatment|October 4, 2020
Immune microenvironment in different molecular subtypes of ductal breast carcinomaMona Sadeghalvad, Hamid-Reza Mohammadi-Motlagh, Nima Rezaei
International Immunopharmacology|November 6, 2021
Therapeutic applications of biosimilar monoclonal antibodies: Systematic review of the efficacy, safety, and immunogenicity in autoimmune disordersSeyedeh Zohreh Mirjalili, Reyhaneh Sabourian, Mona Sadeghalvad, et al.
Archives of Medical Research|July 12, 2014
Soybean Bowman-Birk protease inhibitor (BBI): identification of the mechanisms of BBI suppressive effect on growth of two adenocarcinoma cell lines: AGS and HT29Amirhossein Fereidunian, Mona Sadeghalvad, Maryam Omidi Oscoie, et al.
Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie|August 22, 2022
Cerebral microvascular complications associated with SARS-CoV-2 infection: How did it occur and how should it be treated?Neda Omidian, Pantea Mohammadi, Mona Sadeghalvad, et al.
International Immunopharmacology|April 4, 2023
Erenumab efficacy in migraine headache prophylaxis: A systematic reviewMahsa Bagherzadeh-Fard, Mohammad Amin Yazdanifar, Mona Sadeghalvad, et al.
Iranian Journal of Immunology : IJI|March 31, 2021
Serological and Molecular Tests for COVID-19: a recent updateAmir Hossein Mansourabadi, Mona Sadeghalvad, Hamid-Reza Mohammadi-Motlagh, et al.
Journal of Biochemical and Molecular Toxicology|October 9, 2019
In vivo anti-inflammatory efficacy of the combined Bowman-Birk trypsin inhibitor and genistein isoflavone, two biological compounds from soybeanMona Sadeghalvad, Hamid-Reza Mohammadi-Motlagh, Ali Gorgin Karaji, et al.
Life Sciences|August 5, 2020
The immune system as a target for therapy of SARS-CoV-2: A systematic review of the current immunotherapies for COVID-19Amir Hossein Mansourabadi, Mona Sadeghalvad, Hamid-Reza Mohammadi-Motlagh, et al.
Pageof 2

Showing results (1-10 of 19) with videos related to

Sort By:
Pageof 2
Expert Opinion on Biological Therapy|April 2, 2021
An inflammatory triangle in Sarcoidosis: PPAR-γ, immune microenvironment, and inflammationParnia Jabbari, Mona Sadeghalvad, Nima Rezaei
Frontiers in Immunology|October 9, 2023
Flow cytometric analysis of innate lymphoid cells: challenges and solutionsMona Sadeghalvad, Davit Khijakadze, Mona Orangi, et al.
Breast Cancer Research and Treatment|October 4, 2020
Immune microenvironment in different molecular subtypes of ductal breast carcinomaMona Sadeghalvad, Hamid-Reza Mohammadi-Motlagh, Nima Rezaei
International Immunopharmacology|November 6, 2021
Therapeutic applications of biosimilar monoclonal antibodies: Systematic review of the efficacy, safety, and immunogenicity in autoimmune disordersSeyedeh Zohreh Mirjalili, Reyhaneh Sabourian, Mona Sadeghalvad, et al.
Archives of Medical Research|July 12, 2014
Soybean Bowman-Birk protease inhibitor (BBI): identification of the mechanisms of BBI suppressive effect on growth of two adenocarcinoma cell lines: AGS and HT29Amirhossein Fereidunian, Mona Sadeghalvad, Maryam Omidi Oscoie, et al.
Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie|August 22, 2022
Cerebral microvascular complications associated with SARS-CoV-2 infection: How did it occur and how should it be treated?Neda Omidian, Pantea Mohammadi, Mona Sadeghalvad, et al.
International Immunopharmacology|April 4, 2023
Erenumab efficacy in migraine headache prophylaxis: A systematic reviewMahsa Bagherzadeh-Fard, Mohammad Amin Yazdanifar, Mona Sadeghalvad, et al.
Iranian Journal of Immunology : IJI|March 31, 2021
Serological and Molecular Tests for COVID-19: a recent updateAmir Hossein Mansourabadi, Mona Sadeghalvad, Hamid-Reza Mohammadi-Motlagh, et al.
Journal of Biochemical and Molecular Toxicology|October 9, 2019
In vivo anti-inflammatory efficacy of the combined Bowman-Birk trypsin inhibitor and genistein isoflavone, two biological compounds from soybeanMona Sadeghalvad, Hamid-Reza Mohammadi-Motlagh, Ali Gorgin Karaji, et al.
Life Sciences|August 5, 2020
The immune system as a target for therapy of SARS-CoV-2: A systematic review of the current immunotherapies for COVID-19Amir Hossein Mansourabadi, Mona Sadeghalvad, Hamid-Reza Mohammadi-Motlagh, et al.
Pageof 2